$10 is too low. After interim results, partnership, and key developments in RMDS development, I see us at a market cap of over 500M (~$30/share) in 12 months. A surprise Accelerated Approval in RMDS could put us in the Billions. DO NOT SELL THIS STOCK.
from May 16th dilution:
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) (Cyclacel or the Company), today announced the pricing of the underwritten offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share.
and if you wonder why she says $10:
This offering is expected to close on May 21, 2013, subject to customary closing conditions.
JMP Securities LLC is acting as the sole book-running manager and Janney Montgomery Scott LLC is acting as co-manager for this offering.
I'm thinking of buying and doing my DD. Getting out of ASTX after 4 years since the buyout. need to do something with the money. is it really worth $10?